The Management of COPD and Co-morbidities in a Post-COVID Environment
Patients with respiratory diseases, including asthma and COPD are known to have co-morbidities resulting in disease management complexity. In a world endemic with the SARS-CoV-2 virus, this has added to the complexity with patients having limited access to routine care and the suspension of routine spirometry.
Taking these into account, how should COPD patients be managed in a post-COVID environment in both primary and secondary care? In this webinar, we have invited renowned Professor Hurst to discuss the impact of COVID-19 on patients’ COPD diagnosis and management, as well as challenges associated with co-morbidities.
We hope that you found the content valuable. To ensure that we continue to provide topics and content of interest, we would very much value your feedback by completing a short questionnaire.
Professor John Hurst
Professor of Respiratory Medicine